Crossmark

A habitat radiomics model based on contrast-enhanced MRI for predicting early treatment response to hepatic arterial infusion chemotherapy in patients with unresectable hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1007/s13402-026-01196-4

Published Online: 2026-03-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Guanhui

Zhao, Xuefei

Long, Jie

Li, Yi

Ye, Zhexuan

Rao, Lili

He, Yuqin

Lai, Shujie

Tang, Yuxin

Zhong, Hao

Li, Chao

Li, Jie

Cai, Changxu

Wu, Hao

Lan, Xiang

You, Nan

Wang, Jun

Wen, Liangzhi
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82273484)

project of Chongqing young and middle-aged medical talents
License Information

Text and Data Mining valid from 2026-03-23

Version of Record valid from 2026-03-23
More Information

Article History

Received: 20 January 2026

Accepted: 15 March 2026

First Online: 23 March 2026

Declarations

:

: Following the Declaration of Helsinki, the study received ethical approval from the Ethics Committee of Daping Hospital of Army Medical University (Approval No. 2025(313)), the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University, and the Ethics Committee of the Second Affiliated Hospital of Army Medical University. Informed consent was obtained in advance from all patients participating in the study, permitting the use of their medical records for this research and the publication of the survey results in academic journals.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below